Intravenous albumin is not associated with improved outcomes in cardiac surgery patients

What is this research about?

Albumin is a human protein purified from the plasma of thousands of blood donors. Since the 1960’s, it has been popular for fluid resuscitation in different patient groups, including cardiac surgical patients, who tend to require large volumes of fluid around the time they undergo surgery. Electrolyte solutions called crystalloids, which are not derived from blood, can also be used as part of a fluid management strategy but it is unclear if supplementation of crystalloids with albumin is beneficial in treating blood loss. This research examines whether there are advantages to albumin use in bleeding cardiac surgical patients, a group at high risk for serious complications who often receive blood products.

Published on